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Abstract: Ectopic mediastinal thyroid is a rare entity. Patients are usually euthyroid and symptoms due to mediastinal 
compression are cautionary to investigate intratoracic mass. We represent a female patient who had undergone subtotal 
thyroidectomy 12 years ago and had recurrent hyperthyroidism following an euthyroid period. Antithyroid antibodies were 
negative. Thyroid ultrasonography showed residual thyroid tissue in both sides and multiple nodules on the right side. 
Thyroid scintigraphy showed a nonhomogenously increased tracer uptake on the right thyroid lobe and left lobe was 
rather suppressed. Additionally, a large mass of nonhomogenously increased activity located in the mediastinum which 
was totally seperate from the thyroid gland was detected. MRI images supported that the thoracic mass was an ectopic 
thyroid tissue and surgical excision confirmed benign nodulary hyperplasia. 
The case is intereseting in the way that the patient had a recurrent hyperthyroidism due to toxic nodular hyperplasia of 
the mediastinal ectopic thyroid gland and the pathology was first realised by Technetium-99m (Tc-99m) pertechnetate 
thyroid scan. 
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INTRODUCTION 
Ectopic thyroid is defined as existence of normal 
thyroid tissue anywhere in the body other than normal 
thyroid bed [1]. The prevelance of ectopic thyroid tissue 
has been reported as 7%-10%. Ectopic mediastinal 
thyroid is very rare, constituting <1% of all cases [2-4]. 
Patients with ectopic thyroid tissue are usually 
euthyroid [5]. Hyperthyroidism is a rare condition in 
ectopic mediastinal thyroid tissue and reported 
hyperthyroidism in mediastinal ectopic thyroid cases 
mostly had a diagnosis of Graves disease. This 
situation was probably due to thyroid stimulant 
antibodies. Ectopic thyroid tissue diagnosis in recurrent 
cases is a very rare condition [6]. 
The role of thyroid scintigraphy in diagnosis of 
intrathoracic thyroid has been reported before. 
Radioiodine thyroid scintigraphy is the preffered agent 
for thyroid scintigraphy in order to decrease the 
percentage of attenuation by sternum [7]. In this case 
report, we represent demonstration of benign toxic 
nodular hyperplasia of ectopic mediastinal thyroid by 
Tc-99m pertechneteate thyroid scintigraphy in a patient 
with recurrent hyperthyroidism following subtotal 
thyroidectomy.  
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CASE PRESENTATION 
A 43 years old female patient, who had undergone 
right total, left subtotal thyroidectomy 12 years ago 
(benign nodulary hyperplasia). The patient was 
euthyroid in the following years until she came up with 
shortness of breath, palpitations and fatigue. In blood 
 
Figure 1: Tc-99m pertechnetate thyroid scintigraphy by a 
parallel hole collimator. Increased nonhomogenous 
radiotracer uptake on the right thyroid lobe (due to nodulary 
hyperplasia) and the mass lesion located in the mediastinum. 
Note that the mediastinal activity uptake is not in continuity 
with the thyroid gland. 
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tests, TSH levels were suppressed (0.12mIU/mL 
reference values: 0,34-5,6) while fT4: 1.44ng/dL 
(reference values: 0,61-1,12) and fT3: 3,3 (reference 
values: 2,5-3,9). Antithyroid antibodies (AntiTg, 
AntiTPO and TRAB) were negative. On thyroid 
ultrasonography (USG), right and left lobes and 
isthmus were measured 25X21X59mm, 16X21X45mm, 
and 4.9mm respectively. No nodules were noted on the 
left lobe but there were multiple nodules on the right 
lobe. There were no signs of retrosternal extension. A 
second surgery to the neck was not a preferred option 
due to risk of complications so the patient was referred 
to our clinic as a candidate for radioiodine therapy. On 
thyroid scintigraphy performed before radioiodine 
theraphy, nonhomogenously increased tracer uptake 
was observed on the right thyroid lobe whereas there 
was relatively lower activity uptake on the left lobe of 
the thyroid. Unexpectedly, on paralel hole image, a 
large mass of nonhomogenously increased activity 
located in the mediastinum was also detected. This 
mass lesion was totally separate from the thyroid gland 
(Figure 1). Because the nature of this incidental activity 
retention was obscure, magnetic resonance imaging 
(MRI) of thorax was performed to evaluate ethiology. 
MRI also showed nodular hyperplasia on the right lobe 
of the thyroid. There was a mass lesion in 
46X83X89mm size located in the anterior mediastinum 
including hyperintense regions on T1 and T2 weighed 
images. The mass had solid and cystic components 
(Figures 2a, 2b) and demonstrated minimal contrast 
enhancement following intravenous injection of 
Gadolinum (Figure 3). Trachea was deviated to right 
and subcutaneous vascular structures were dilated due 
to compression of great vessels in the mediastinum 
(Figure 4). The mass was totally separate from the 
thyroid (Figure 5) Preoperatively, the differential 
diagnosis of the mass lesion was not possible as 
retrosternal goiter and other mediastinal pathologies 
like thymoma could both show Tc-99m pertechnetate 
uptake [8]. Surgical removal of the lesion enlightened 
the diagnosis. Histopathological examination of the 
encapsulated lesion which was 235gr in weight and 
11X8,5X45mm in size revealed benign nodular 
hyperplasia (Figure 6). No surgery was planned for the 
recurrent thyroid tissue due to high risk of 
complications. Hyperthyroidism is now under control 
with Methymasole 10mg/day. 
DISCUSSION 
Intrathoracic thyroid tissue is mostly nonfunctional 
and thyrotoxicosis caused by intrathoracic goiter has 
been reported in a few cases [9]. These case reports 
involve Graves disease diagnosed in mediastinal 
thyroid [10]. It is interesting in this case that recurrent 
hyperthyroidism due to ectopic mediastinal toxic 
nodulary hyperplasia was detected in a previously 
thyroidectomised patient. On thyroid scintigraphy, 
mediastinal mass which showed no continuity with the 
overlying thyroid, was Tc-99m pertechnetate avid. 
However mediastinal pathologies other than ectopic 
thyroid tissue have been previously reported to be 
positive on thyroid scan [8, 11, 12]. So we performed 
other confirmatory examinations before surgery. MRI 
results were also equivocal because no connection 
between the lesion and thyroid could be demonstrated. 
In surgery the lesion was observed to be encapsulated 
 
Figure 2a and 2b: T1W images on axial and sagittal plane. The lesion was located in the anterior mediastinum starting from the 
region anterior to the ascending aorta in pulmonary truncus level and extending to the superior anteriorly to the trachea. The 
lesion had cystic and solid components.  
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and existed in the anterior mediastinum seperately 
from the overlying thyroid tissue. Histopathology 
confirmed nodulary hyperplasia. This tissue was an 
ectopic thyroid which became apparent slowly in the 
years following subtotal thyroidectomy. The patient was 
euthyroid in the postoperative period probably due to 
this hidden thyroid.  
 
Figure 6: Macroscopic appearance of the surgically excised 
anterior mediastinal mass. 
In the literature, there are a few case reports 
demonstrating radioiodine (I-131) uptake in incidental 
mediastinal thyroid tissue and thyroid scintigraphy with 
I-131 has been reported to be of diagnostic value in 
intrathoracic goiter [13]. I-131 can be a better agent to 
evaluate retrosternal pathologies with higher energy 
and less amount of photons attenuated by sternum, but 
in this case, we were able to demonstrate the function 
of the mediastinal mass by Tc-99m pertechnetate 
probably because the patient was hyperthyroid and the 
activity uptake was very high in the ectopic thyroid 
gland. 
CONLUSION 
Hyperthyroid patients with possible symptoms of a 
mediastinal mass should be evaluated carefully in the 
preoperative period in order not to miss this rare 
pathology. 
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Figure 3: Axial images of T1W postcontrast images showing 
minimal contrast enhancement. 
 
Figure 4: T2 fat suppressed sequences on axial plane. 
Vascularity increase in the subcutaneous tissues of the 
mediastinum. 
 
Figure 5: Coronal T1W images demonstrating that there was 
no connection between the mediastinal mass and the 
adjacent thyroid. 
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